These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9263513)
1. [p53 alterations and chromosome 17 aberrations in non-small cell lung cancer]. Tsuji T; Tagawa Y; Hisamatsu T; Nakamura S; Terada R; Sawai T; Yasutake T; Ayabe H Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():263-8. PubMed ID: 9263513 [TBL] [Abstract][Full Text] [Related]
2. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680 [TBL] [Abstract][Full Text] [Related]
3. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
4. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258 [TBL] [Abstract][Full Text] [Related]
5. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma. McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210 [TBL] [Abstract][Full Text] [Related]
6. Correlation of model chromosome number of cultured non-small cell lung carcinomas with DNA index of solid tumor tissue. Siegfried JM; Ellison DJ; Resau JH; Miura I; Testa JR Cancer Res; 1991 Jun; 51(12):3267-73. PubMed ID: 1645617 [TBL] [Abstract][Full Text] [Related]
7. p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Marchetti A; Buttitta F; Merlo G; Diella F; Pellegrini S; Pepe S; Macchiarini P; Chella A; Angeletti CA; Callahan R Cancer Res; 1993 Jun; 53(12):2846-51. PubMed ID: 8389245 [TBL] [Abstract][Full Text] [Related]
8. [Detection of loss of heterozygosity by microsatellite probe and DNA content analysis]. Chiba W; Sawai S; Ikeda S; Kinoshita M; Hatama T; Shin S; Fujimoto T; Miyajima S; Wazawa H; Hanawa T Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():158-63. PubMed ID: 7611781 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Fong KM; Kida Y; Zimmerman PV; Ikenaga M; Smith PJ Cancer Res; 1995 Oct; 55(19):4268-72. PubMed ID: 7671234 [TBL] [Abstract][Full Text] [Related]
10. Comparison of features of human lung cancer cell lines and their corresponding tumors. Wistuba II; Bryant D; Behrens C; Milchgrub S; Virmani AK; Ashfaq R; Minna JD; Gazdar AF Clin Cancer Res; 1999 May; 5(5):991-1000. PubMed ID: 10353731 [TBL] [Abstract][Full Text] [Related]
11. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung. Sachse R; Murakami Y; Shiraishi M; Hayashi K; Sekiya T Oncogene; 1994 Jan; 9(1):39-47. PubMed ID: 8302602 [TBL] [Abstract][Full Text] [Related]
12. Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer. Panani AD; Maliaga K; Babanaraki A; Bellenis I Anticancer Res; 2009 Nov; 29(11):4483-7. PubMed ID: 20032395 [TBL] [Abstract][Full Text] [Related]
13. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations. Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877 [TBL] [Abstract][Full Text] [Related]
14. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade. Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469 [TBL] [Abstract][Full Text] [Related]
15. Loss of TP53-DNA interaction induced by p.C135R in lung cancer. Aranda M; Gonzalez-Nilo F; Riadi G; Díaz V; Perez J; Martel G; Hainaut P; Mimbacas A Oncol Rep; 2007 Nov; 18(5):1213-7. PubMed ID: 17914575 [TBL] [Abstract][Full Text] [Related]
16. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
17. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer. Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091 [TBL] [Abstract][Full Text] [Related]
18. ERBB2 kinase domain mutation in the lung squamous cell carcinoma. Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927 [TBL] [Abstract][Full Text] [Related]
19. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410 [TBL] [Abstract][Full Text] [Related]
20. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer]. Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]